Home/Pipeline/Portfolio Expansion (Generics)

Portfolio Expansion (Generics)

Various Oncology Indications

CommercialActive

Key Facts

Indication
Various Oncology Indications
Phase
Commercial
Status
Active
Company

About Bendalis

Bendalis GmbH is a private, commercial-stage pharmaceutical company specializing in generic oncology and supportive care products. Founded in 2006 and headquartered in Oberhaching (near Munich), it operates with a therapeutics business model, generating revenue through the distribution of a portfolio of established injectable and oral generic drugs. The company leverages a close partnership with its sister company, Lyomark Pharma GmbH, a contract manufacturer, and focuses on the German and select international markets through a network of distribution partnerships.

View full company profile

Other Various Oncology Indications Drugs